ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,613, issued on Nov. 25, was assigned to BAHCESEHIR UNIVERSITESI (Istanbul), AGRI IBRAHIM CECEN UNIVERSITESI STRATEJI DAIRE BASK. (Istanbul), ISTANBUL GEDIK UNIVERSITESI (Istanbul) and ISTANBUL TEKNIK UNIVERSITESI REKTORLUGU (Istanbul).

"Selective MAO-B inhibitor DRG-MAOB-2 for use in treatment of neurodegenerative diseases" was invented by Serdar Durdagi (Besiktas/Istanbul, Turkey), Mine Yurtsever (Besiktas/Istanbul, Turkey), Yusuf Serhat Is (Besiktas/Istanbul, Turkey), Busecan Aksoydan (Besiktas/Istanbul, Turkey) and Murat Senturk (Besiktas/Istanbul, Turkey).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compound shown with ...